4.7 Article

Development and validation of a microfluidic immunoassay capable of multiplexing parallel samples in microliter volumes

期刊

LAB ON A CHIP
卷 15, 期 15, 页码 3211-3221

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c5lc00398a

关键词

-

资金

  1. National Institute of Health [P41EB002503, UH2TR000503]
  2. National Institute of Health Rutgers Biotechnology Training Program [T32GM008339]
  3. National Science Foundation Integrated Science and Engineering of Stem Cells Program [DGE0801620]
  4. New Jersey Commission on Brain Injury Research [CBIR12IRG019]
  5. Div Of Chem, Bioeng, Env, & Transp Sys
  6. Directorate For Engineering [1512170] Funding Source: National Science Foundation

向作者/读者索取更多资源

Immunoassays are widely utilized due to their ability to quantify a vast assortment of biomolecules relevant to biological research and clinical diagnostics. Recently, immunoassay capabilities have been improved by the development of multiplex assays that simultaneously measure multiple analytes in a single sample. However, these assays are hindered by high costs of reagents and relatively large sample requirements. For example, in vitro screening systems currently dedicate individual wells to each time point of interest and this limitation is amplified in screening studies when the investigation of many experimental conditions is necessary; resulting in large volumes for analysis, a correspondingly high cost and a limited temporal experimental design. Microfluidics based immunoassays have been developed in order to overcome these drawbacks. Together, previous studies have demonstrated on-chip assays with either a large dynamic range, high performance sensitivity, and/or the ability to process samples in parallel on a single chip. In this report, we develop a multiplex immunoassay possessing all of these parallel characteristics using commercially available reagents, which allows the analytes of interest to be easily changed. The device presented can measure 6 proteins in 32 samples simultaneously using only 4.2 mu L of sample volume. High quality standard curves are generated for all 6 analytes included in the analysis, and spiked samples are quantified throughout the working range of the assay. In addition, we demonstrate a strong correlation (R-2 = 0.8999) between in vitro supernatant measurements using our device and those obtained from a bench-top multiplex immunoassay. Finally, we describe cytokine secretion in an in vitro inflammatory hippocampus culture system, establishing proof-of-concept of the ability to use this platform as an in vitro screening tool. The low-volume, multiplexing abilities of the microdevice described in this report could be broadly applied to numerous situations where sample volumes and costs are limiting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据